| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b38fa9d81ac8c590ca60b09f52e7a6cf |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015 |
| filingDate |
2016-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5885e9cd79e7b5dfae8c04f5744e6f0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5526ac768913f53d21b14eac3d7798c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_012fe0b5050914360a8a2b2b5c193ef2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08eba9a894c6ec4dd486657cd905e70d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0abc2e987d8ab2a722e15bc7e99ab7ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c3b521100d339ef099fbb3f16f5c029
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7eb6f1aee45aa6af0d8a6ca98d78ae08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70743d643416529b2ebe0bbe6ecb94f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bca11272aac140fb27a90cc73757b42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8a5bf99f5843f601adee40964bd80ce |
| publicationDate |
2018-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018200227-A1 |
| titleOfInvention |
Use of 2-(5S-methyl-2-oxo-4R-phenyl-pyrrolidin-1-yl)-acetamide in the Treatment of Seizures |
| abstract |
Use of 2-(55-Methyl-2-oxo-4R-phenyl-pyrrolidin-1-yl)-acetamide or its pharmaceutically acceptable salt in manufacture of a medicament for prophylaxis and treatment of seizure. |
| priorityDate |
2015-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |